Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target.
Autorzy:
Muehlebach ME; Cancer Research Doctoral Program, University of Nebraska Medical Center, Omaha, Nebraska, USA. HolsteinSA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma.
Autorzy:
Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, 986840 Nebraska Medical Center, Omaha, NE 68198, USA. HolsteinSA; Department of Internal Medicine, University of Nebraska Medical Center, 986840 Nebraska Medical Center, Omaha, NE 68198, USA.
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma.
Autorzy:
Haney SL; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Varney ML; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Williams JT; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. Smith LM; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA. Talmon G; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. HolsteinSA; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 68198, USA. sarah.holstein@unmc.edu.
Future Directions in Maintenance Therapy in Multiple Myeloma.
Autorzy:
HolsteinSA; Department of Internal Medicine, Division of Oncology and Hematology, University of Nebraska Medical Center, Omaha, NE 68198, USA. Suman VJ; Department of Health Sciences, Division of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA. Hillengass J; Myeloma Service, Roswell Park Comprehensive Cancer Center, Department of Medicine, Buffalo, NY 14203, USA. McCarthy PL; Roswell Park Comprehensive Cancer Center, Transplant and Cellular Therapy Program, Department of Medicine, Buffalo, NY 14203, USA.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 May 24; Vol. 10 (11). Date of Electronic Publication: 2021 May 24.
Visual Pathway Degeneration in Chemotherapy-Related Neurotoxicity: A Review and Directions for Future Research.
Autorzy:
Anderson DE; Department of Ophthalmology & Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA. HolsteinSA; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA. Kedar S; Department of Ophthalmology & Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Pokaż więcej
Źródło:
Neuro-ophthalmology (Aeolus Press) [Neuroophthalmology] 2020 Jan 06; Vol. 44 (3), pp. 139-147. Date of Electronic Publication: 2020 Jan 06 (Print Publication: 2020).
Modeling the Effects of Multiple Myeloma on Kidney Function.
Autorzy:
Walk JC; Concordia College, Department of Mathematics, Moorhead, 56562, USA. . Ayati BP; University of Iowa, Department of Mathematics, Iowa City, 52242, USA.; University of Iowa, Program in Applied Mathematical and Computational Sciences, Iowa City, 52242, USA.; University of Iowa, Department of Orthopaedics and Rehabilitation, Iowa City, 52242, USA. HolsteinSA; University of Nebraska Medical Center, Division of Oncology & Hematology, Omaha, 68198, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Feb 11; Vol. 9 (1), pp. 1726. Date of Electronic Publication: 2019 Feb 11.
Simultaneous Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-MS/MS.
Autorzy:
Chhonker YS; Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE 68198, USA. . Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. . Bala V; Department of Pharmaceutical Sciences, Mohanlal Sukhadia University, Udaipur, Rajasthan 313001, India. . HolsteinSA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. sarah.holstein@unmc.edu.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. sarah.holstein@unmc.edu. Murry DJ; Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha, NE 68198, USA. .; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA. .
Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
Autorzy:
Haney SL; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. . Wills VS; Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA. . Wiemer DF; Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA. . HolsteinSA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. sarah.holstein@unmc.edu.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
